Back

Prognostic value of 24-hour wearable heart rate data in right-sided heart failure patients with tricuspid regurgitation

29 August 2025 (07:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: Smart wearables: bridging technology and everyday life Wearables ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Valentine Ojonugwa Idakwo

Ludwig Maximilians University, Munich (Germany)

6 More presentations in this session

Presentation thumbnail
Do wearable electronic devices after a cardiac rehabilitation programme improve adherence to physical exercise?
Doctor C. Jimenez Martinez (Alcorcon, Madrid, ES)
Abstract Slides Video
Presentation thumbnail
Is a single-lead smartwatch ECG capable of detecting a wider spectrum of arrhythmias in clinical practice?
Ms N. Van Steijn (Amsterdam, NL)
Abstract Slides Video
Presentation thumbnail
Wearable-derived acoustic biomarkers for ascending aortic dilation evaluation in bicuspid aortic valve disease
Doctor W. Zhang (Shanghai, CN)
Abstract Slides Video
Presentation thumbnail
Assessment of diastolic function using AI-enhanced electrocardiogram and prognosis in patients with left bundle branch block
Doctor G. Tsaban (Rochester, US)
Abstract Slides Video
Presentation thumbnail
Pilot study on AI-enhanced smartwatch ECG for prospective monitoring for detecting left ventricular systolic dysfunction in real-world settings
Doctor J. Son (Seoul, KR)
Abstract Slides Video

Access the full session

Session thumbnail
Smart wearables: bridging technology and everyday life

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025
You may be interested in
thumbnail
Congress Presentation
Prognostic impact of maximal nocturnal heart rate in heart failure patients with an implantable electronic device
thumbnail
Congress Presentation
Clinical characteristics and prognostic significance of different heart failure types stratified by ejection fraction in patients with acute heart failure and severe tricuspid regurgitation
thumbnail
Congress Presentation
Impact of treatment modality on prognostic features in patients with severe tricuspid regurgitation

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources